Maryam B. Lustberg

13.0k total citations · 3 hit papers
326 papers, 6.4k citations indexed

About

Maryam B. Lustberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Maryam B. Lustberg has authored 326 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 223 papers in Oncology, 88 papers in Pulmonary and Respiratory Medicine and 48 papers in Cancer Research. Recurrent topics in Maryam B. Lustberg's work include Cancer Treatment and Pharmacology (86 papers), Cancer survivorship and care (59 papers) and Cancer-related cognitive impairment studies (49 papers). Maryam B. Lustberg is often cited by papers focused on Cancer Treatment and Pharmacology (86 papers), Cancer survivorship and care (59 papers) and Cancer-related cognitive impairment studies (49 papers). Maryam B. Lustberg collaborates with scholars based in United States, Italy and Canada. Maryam B. Lustberg's co-authors include Charles L. Loprinzi, Guido Cavaletti, Bhuvaneswari Ramaswamy, Judith A. Paice, Nina D. Wagner‐Johnston, Thomas J. Smith, Jonathan Bleeker, Cynthia Chauhan, Christina Lacchetti and Mary Lou Smith and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Maryam B. Lustberg

285 papers receiving 6.3k citations

Hit Papers

Prevention and Management of Chemotherapy-Induced Periphe... 2014 2026 2018 2022 2014 2020 2023 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
    2014 887 citations Maryam B. Lustberg, Mary Lou Smith et al. Journal of Clinical Oncology profile →
  2. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
    2020 615 citations Daniel L. Hertz, Maryam B. Lustberg et al. Journal of Clinical Oncology profile →
  3. Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
    2023 123 citations Maryam B. Lustberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryam B. Lustberg United States 40 4.0k 1.1k 953 848 773 326 6.4k
Bryan P. Schneider United States 37 3.3k 0.8× 1.2k 1.1× 1.7k 1.8× 652 0.8× 490 0.6× 165 6.3k
Kathryn J. Ruddy United States 44 4.1k 1.0× 1.3k 1.1× 1.4k 1.5× 648 0.8× 507 0.7× 324 8.7k
Bernd Holleczek Germany 48 2.6k 0.7× 1.2k 1.0× 1.7k 1.8× 185 0.2× 1.2k 1.6× 237 8.0k
Irene Helenowski United States 39 1.7k 0.4× 967 0.8× 898 0.9× 200 0.2× 415 0.5× 232 5.7k
Edoardo Botteri Italy 45 3.6k 0.9× 1.4k 1.2× 882 0.9× 438 0.5× 522 0.7× 181 8.2k
Kathleen M. Egan United States 49 2.8k 0.7× 1.0k 0.9× 1.6k 1.7× 271 0.3× 654 0.8× 159 7.8k
Patrick J. Flynn United States 51 6.9k 1.7× 2.6k 2.3× 2.2k 2.3× 243 0.3× 331 0.4× 145 11.1k
Charles L. Shapiro United States 60 7.3k 1.9× 2.2k 1.9× 3.8k 3.9× 488 0.6× 621 0.8× 233 13.1k
Stefan Glück United States 40 3.2k 0.8× 1.1k 1.0× 1.2k 1.2× 114 0.1× 194 0.3× 199 5.6k
Nicholas Pavlidis Greece 60 8.7k 2.2× 2.4k 2.1× 2.3k 2.4× 401 0.5× 416 0.5× 324 13.2k

Countries citing papers authored by Maryam B. Lustberg

Since Specialization
Citations

This map shows the geographic impact of Maryam B. Lustberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam B. Lustberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam B. Lustberg more than expected).

Fields of papers citing papers by Maryam B. Lustberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam B. Lustberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam B. Lustberg. The network helps show where Maryam B. Lustberg may publish in the future.

Co-authorship network of co-authors of Maryam B. Lustberg

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam B. Lustberg. A scholar is included among the top collaborators of Maryam B. Lustberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam B. Lustberg. Maryam B. Lustberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yang, Kevin M. Huang, Eman Ahmed, et al.. (2025). OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor–Associated Arthralgia Susceptibility. Cancer Research Communications. 5(3). 497–511.
2.
Haywood, Darren, Alexandre Chan, Raymond J. Chan, et al.. (2025). The MASCC COG-IMPACT: An unmet needs assessment for cancer-related cognitive impairment impact developed by the Multinational Association of Supportive Care in Cancer. Supportive Care in Cancer. 33(2). 120–120. 1 indexed citations
3.
Tarantino, Paolo, Julia Foldi, Pamela R. Soulos, et al.. (2025). Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer. JNCI Journal of the National Cancer Institute. 117(11). 2327–2335. 4 indexed citations
4.
Mayer, Erica L., Mary Lou Smith, Annie Guérin, et al.. (2025). Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2− early breast cancer: a discrete choice survey study. Breast Cancer Research and Treatment. 211(1). 121–130. 1 indexed citations
5.
6.
Marczyk, Michał, et al.. (2024). Trends in breast cancer–specific death by clinical stage at diagnoses between 2000 and 2017. JNCI Journal of the National Cancer Institute. 117(2). 287–295. 3 indexed citations
7.
Fernandez, Aileen I., Andrew Elliott, Maryam B. Lustberg, et al.. (2024). NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer. Breast Cancer Research. 26(1). 175–175. 4 indexed citations
8.
Lustberg, Maryam B., et al.. (2024). Long-Term Considerations for Young Breast Cancer Patients: Fertility, Sexual Health, and Quality of Life. Current Breast Cancer Reports. 16(2). 227–236. 1 indexed citations
9.
10.
Quiroga, Dionisia, Robert Wesolowski, Brooke Benner, et al.. (2024). An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer. Cancer Control. 31. 2925668237–2925668237. 3 indexed citations
11.
12.
Hertz, Daniel L., Cindy Tofthagen, Emanuela Rossi, et al.. (2023). Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy. Supportive Care in Cancer. 32(1). 48–48. 6 indexed citations
13.
Sukumar, Jasmine, Sagar Sardesai, Ai Ni, et al.. (2023). Abstract P1-02-03: Real World Treatment Patterns of Adjuvant Endocrine Therapy and Ovarian Suppression in Premenopausal HR+/HER2+ Breast Cancer. Cancer Research. 83(5_Supplement). P1–2. 1 indexed citations
14.
Nepal, Mahesh R., Yang Li, Zahra Talebi, et al.. (2022). Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity. Cancer Research Communications. 2(11). 1334–1343. 7 indexed citations
15.
El‐Jawahri, Areej, Alison R. Walker, Deborah Russell, et al.. (2022). Psychological Distress in Young Adults with Acute Myeloid Leukemia Undergoing Induction Chemotherapy. Journal of Adolescent and Young Adult Oncology. 12(4). 592–598. 4 indexed citations
16.
Schnell, Patrick, et al.. (2020). Palliative Care Referral Patterns for Adolescent and Young Adult Patients at a Comprehensive Cancer Center. Journal of Adolescent and Young Adult Oncology. 10(1). 109–114. 19 indexed citations
17.
Bohlius, Julia, Kari Bohlke, Roberto Castelli, et al.. (2019). Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. Blood Advances. 3(8). 1197–1210. 112 indexed citations
18.
Hou, Yanjun, Hiroaki Nitta, Lai Wei, et al.. (2018). PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer. The Breast Journal. 24(6). 911–919. 56 indexed citations
19.
Foy, Kevin, James L. Fisher, Maryam B. Lustberg, et al.. (2018). Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women. npj Breast Cancer. 4(1). 7–7. 38 indexed citations
20.
Hyde, Parker N., Maryam B. Lustberg, Vincent Miller, Richard A. LaFountain, & Jeff S. Volek. (2017). Pleiotropic effects of nutritional ketosis: Conceptual framework for keto-adaptation as a breast cancer therapy. Cancer Treatment and Research Communications. 12. 32–39. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan P. Schneider Breakdown of academic impact, for papers by Kathryn J. Ruddy Breakdown of academic impact, for papers by Bernd Holleczek Breakdown of academic impact, for papers by Irene Helenowski Breakdown of academic impact, for papers by Edoardo Botteri Breakdown of academic impact, for papers by Kathleen M. Egan Breakdown of academic impact, for papers by Patrick J. Flynn Breakdown of academic impact, for papers by Charles L. Shapiro Breakdown of academic impact, for papers by Stefan Glück Breakdown of academic impact, for papers by Nicholas Pavlidis
Rankless by CCL
2026